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A series of 198 consecutive patients with acute myocardial
infarction were prospectively studied before hospital dis-
charge and during 24.0 t 8.6 months of follow-up. A
predischarge i irombus was found In 38 (31%) of 124
patients with anterior Infarction but in none of 74 patients
with inferior infarction (p < 0 .001) . Early thrombolytic
therapy in 34 patients did not decrease the rate of thrombus
occurrence. Acute anterior infarction, ejection fraction
c35% and apical dyskinesia or aneurysm (but not akinesia)
were significantly related to the appearance of thrombus
during hospitalization by stepwise logistic regression anal .
ysis .
Echocardiographic follow-up of 159 patients for at least
6 months (mean 26.6 ± 8.4) revealed that thrombus
disappeared in 14 (48%) of 29 . Disappearance of thrombus
was related to predischarge apical akinesia (but not dyski-
nesla) and to warfarin therapy during the follow-up period .
A new thrombus first appeared after hospital discharge in
13 of 130 patients, and In 7 of the 13 it resolved during
further follow-up . Thus, 30% (13 of 42) of thrombi in these
patients appeared after discharge from the hospital .
Left ventricular thrombus occurs frequently in the course of
acute myocardial infarction and is associated with increased
embolic risk (1-6) . Acute anterior infarction and severe
apical asynergy have been uniformly correlated with forma-
tion of thrombus (7-19) . Clinical (8-10,18-21) and labora-
tory (15-17) markers of the extent of myocardial damage as
well as administration of anticoagulant (22-26) or fibrinolytic
From The Heiden Department of Cardiology
. Bikur Cholim Hospital and
Hebrew University Hadassah-Medical School, Jerusalem
. Israel .
Manuscript received July 5
. 1989 : revised manuscript received October
18, 1999
. accepted October 25 . 1989.
Address for
reprints
;
Andre Keren
. MD. The Heiden Dar-rtment of
Cardiology, Bikur Cholim Hospital
. P.O. Box 492. Jerusalem 91000
. Israel .
®1990 by the American College of Cardiology
JACC Vol . 15, No . 4
March 15,1990 :790-800
Three factors were related to occurrence of new thrombi
during the follow-up period: deterioration in left ventricu-
lar ejection fraction, predischarge ejection fraction X35%
and ventricular aneurysm or dyskinesia. Systemic embo-
lism occurred in six patients, all with a p ischarge
thrombus p < 0.001) . Mobility of the thrombus was the
only variable significantly related to subsequent embolic
events (p = 0 .001) by logistic regression analysis. Thus, the
predischarge echocardiogram identifies patients with
thrombus and those at highest risk of embolic events . It can
indicate patients who are likely to have thrombus resolution
and those at risk of developing a new thrombus after
hospital discharge. Follow-up echocardiograms may help in
guiding the length of long-term anticoagulant therapy .
Four additional patients with a predischarge apical
mobile thrombus (not part of the consecutive series) re-
ceived thrombolytic therapy. In two of the four, lysis of
thrombus was achieved without complications, but systemic
embolism occurred in the other two, and proved fatal in
one.
(J Am Coll Cordial 1990;15:790-800)
(27-30) therapy during the acute phase of infarction have
been shown to have a variable influence on the incidence of
thrombi. A thrombus disappearance rate ranging from 20%
to 71% (8,10,11,19,20,27,31-33) and first appearance of left
ventricular thrombus after hospital discharge (8,13,20) have
been reported . Factors related to thrombus appearance in
the posthospitalization period and its embolic potential have
not been systematically evaluated in prospective studies .
Echocardiography is both sensitive and specific in the
detection and morphologic characterization of ventricular
thrombus (21,34-37) . Protrusion and mobility of the throm-
bus have been variably (13% to 83%) associated with in-
creased risk of embolization (12-18), but it has been claimed
(18) that spontaneous variability in thrombus shape and
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mobility significantly decreases the prognostic value of these
characteristics .
The present study prospectively investigated 198 consec-
utive patients with acute transmural myocardial infarction .
The patients had long-term clinical, echocardiographic and
nuclear angiographic follow-up evaluations to attempt to
define 1) factors related to the formation of thrombus during
the acute phase of infarction ; 2) factors related to disappear-
ance of thrombus during the follow-up period ; 3) the fre-
quency of and factors related to appearance of a new
thrombus during the follow-up period-, and 4) the risk of
embolization of thrombus detected either before or after
hospital discharge. Pertinent experience is reported in four
additional patients in whom fibrinolytic therapy was used
during the late phase of acute infarction to achieve lysis of a
mobile thrombus .
Methods
Study patients. The study group included 198 consecu-
tive patients who survived an acute transmural myocardial
infarction, had technically adequate predischarge echocar-
diograms and had no additional cardiac or systemic illness
that could affect left ventricular function or long-term prog-
nosis. They represented 93% of the 212 patients with acute
infarction discharged from the hospital between February
1985 and January 1987 . Excluded were 2 patients with
inadequate echocardiograms and 10 with primary myocar-
dial or valvular heart disease, emergency surgery or coca .,-
nary angioplasty during hospitalization or a systemic ilip-2ss
that could affect long-term prognosis . Two additional pa-
tients with previous infarction and echocardiographic docu-
mentation of left ventricular thrombus < 12 h after their
hospitalization were excluded because thrombus appearance
could not be attributed with certainty to the new infarction
CW the 198 patients included in the study, 168 were men
and 30 were women ; the mean age was 62.3 ± 11
.8 years
(range 32 to 86) . Echocardiography was performed 10.6 ±
4.1 days (range 7 to 21) after the acute event . Transmural
myocardial infarction was diagnosed by typical history,
characteristic increase in serum creatine kinase, glutamic
oxaloacetic transaminase and lactic dehydrogenase enzyme
levels, and development of diagnostic Q waves on the
electrocardiogram (ECG) . The location of the infarction was
defined from the ECG (38) . Patients with lateral and with
combined acute
anterior and inferior infarction were in-
cluded in the group with anterior infarction .
Six weeks after hospital discharge,
the patients had their
first clinical and echocardiographic follow-up evaluation,
and these examinations were repeated every 3 months
during the first year and every 6 months thereafter . Nuclear
angiography was also performed before hospital discharge,
every 6 months during the first year and every 12 months
thereafter .
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Echocardiography. Two-dimensional echocardiography
was performed with use of a Hewlett Packard phased array
ultrasonograph and a medium and short focused 2 .5 or 3 .5
MHz transducer, or both . Patients with previous infarction
and those who received streptokinase shortly after admis-
sion had their first echocardiogram performed within 12 h of
hospitalization
. Each study included all standard echocar-
diographic views (36) . In assessing the apical area, images
were recorded with different gain settings and angulations of
the transducer, and a short focused transducer was used in
each patient to minimize near field artifacts and to differen-
tiate muscular trabeculae and aberrant bands from thrombus
(21,34,36) .
Left ventricular thrombus was defined as an echo-dense
mass, contiguous but distinct from the endocardium, located
in an area of asyne .,-gy that was seen in both systole and
diastole in at least two echucardiographic views (8,21,34-
36). The agreement of two independent reviewers was re-
quired for diagnosis of thrombus and other echocardio-
graphic variables . Theri-, was 96% interobserver agreement
for thrombus and 92% agreement for characteristics of wall
motion abnormalities adjacent to the cardiac mass . In cases
of disagreemem, a decision was reached by joint review of
the case .
A thrombus was classified as either mural (if the free
margin of the mass was concave following the curvature of
the endocardial surface) or protruding (if the free margin was
convex in relation to the adjacent endocardium) ; it was
considered mobile if any portion of it moved independent of
the underlying myocardium (6,12-15) . The area of the throm-
bus was defined by tracing its contour on a still frame image
(16) using the built-in calibrated measurement system of the
echocardiographic machine . During follow-up evaluations, a
?50% change in thrombus area was considered to be a
significant change in thrombus size . Left ventricular aneu-
rysm was defined as a localized area of akinesia or dyskine-
sia that deformed the ventricular contour in both systole and
diastole 16,15 .20) .
Wall inotion of the apical area, where most of the
thrombi predictably (6-16) occurred, was qualitatively
graded as normal . hypokinetic, akinetic or dyskinetic ; 90%
of dyskinetic segments were: located in the area of an apical
aneurysm. Therefore, apical dyskinesia and left ventricular
aneurysm (the latter associated in some cases with apical
akinesia) were analyzed as a single category for statistical
correlations. Akinesia without aneurysm was separately
evaluated. Changes from hypokinesia to akinesia or from
akinesia to dyskinesia were defined as deterioration in wall
motion, and improvement was diagnosed when the opposite
changes occurred .
Nuclear angiography . Left ventricular ejection fraction
was evaluated using multiple gated technetium blood pool
scans on an Elscint 400 Apex gamma camera . A change of
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>5% in ejection fraction was defined as deterioration or
improvement in global ventricular contractility (39) .
Early fibrinolytic and long-term anticoagulant therapy .
Thirty-four patients admitted to the emergency room within
4 h of the onset of typical chest pain, with ST segment
elevation in at least two ECG leads and lack of response to
sublingual nitrates received fibrinolytic therapy (27) . After
intravenous irnfusk i of hydrocortisone (100 mg), streptoki-
nase (1 .5 million U) and heparin (15 IU/kg per h) were also
given intravenously . The hematologic effect of the medica-
tion was assessed by repeat fibs inogen level and partial
thromboplastin time measurements . After 24 h, the heparin
dose was adjusted to maintain the partial thromboplastin
time in the therapeutic range (70 to 140 s) . Successful
reperfusion was defined using clinical and angiugraphic
criteria (30) . Patency of the infarct-related artery was eval-
uated in each case on coronary arteriograms obtained 5 to 10
days after hospitalization . Before hospital discharge, oral
warfarin was started, and neparin administration was
stopped when the prothrombin time reached the therapeutic
range (20% to 30%). Changes in the warfarin regimen and
bleeding complications were recorded .
Systemic embolism . The c iteria for systemic emboliza-
tion were similar with those described in previous studies
(11,15-17) . The diagnosis of embolism to a limb required the
presence of sudden circulatory compromise and pathologic
confirmation. A cerebrovasculat embolic event was diag-
nosed in the presence of a sudden neurologic deficit in the
absence of a previous transient ischemic attack and a carotid
artery bruit, normal carotid Doppler recording and indepen-
dent confirmation of the embolic; nature of the event by a
neurologist. In patients with hypertension, nonlacunar cere-
bral infarction had to be demonstrated by computed tomog-
raphy .
Statistical analysis . Clinical, echocardiographic and nu-
clear angiographic variables were evaluated by univariate
and multivariate analysis . Continuous variables were ex-
pressed as mean values ± SD. Differences between two
mean values were evaluated by a paired or unpaired two-
tailed Student t test . Differences among three mean values
were evaluated with one-way analysis of variance . Categoric
variables were tested by chi-square test or Fisher's exact
test where indicated .
Stepwise logistic regression analysis (40) was used to
define explanatory variables for four major events ("risk
groups") . 1) The risk of thrombus formation during hospi-
talization was evaluated in the original 198 patients ; 2) the
risk of systemic embolization was evaluated in 189 patients
(9 patients were lost to follow-up) who had a clinical follow-
up period of 24.0 ± 8.6 months (range I to 48) ; 3) factors
related to the disappearance of thrombus ; and 4) the risk of
new thrombus appearance during the follow-up period were
evaluated in 159 patients with s6 months of echocardio-
graphic follow-up study (range 6 to 48 months, mean 26 .6 ±
m134 n-74
at-86
n-94
0-0
0066
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Figure 1 . Myocardial infarction (Ml) location, therapy and presence
of left ventricular thrombus (LVT+) during initial hospitalization of
98 patients . Ant = anterior; Inf = inferior ; STK + = streptakinase
administered within 3 h of chest pain ; STK - = no streptokinase
administered .
8.4) . Thus, patients who had an echocardiographic follow-up
period of <6 months because of death, cardiac surgery or
coronary angioplasty performed before that time period
were excluded from this analysis .
The stepwise regression analysis defined the beta coeffi-
cient and its standard error as well as the corrected odds
ratio (comparing the risk and reference groups) for each
explanatory variable selected (40) .
Attempt to lyre left ventricular thrombi . After conclusion
of our study, four additional patients had a large protruding
mobile ventricular thrombus . Each received intravenous
streptokinase or urokinase in an attempt to achieve lysis of
tee thrombus. Streptokinase was given in doses usually
employed in patients with a thrombosed prosthetic valve
(41,42), namely, a 375,000IU bolus followed by 70,000 IU/h
and heparin, 1,000 U/h . Urokinase was given as previously
described by Kremer et al . (43), as a 250,000 IU bolus
followed by 75,000 IU/h and heparin, 1,000 U/h . After this,
warfarin therapy was started . Two of these patients have
been previously described (44,45), but the complications
noted and the relevance of these cases to those described in
the consecutive series warrant inclusion of this experience .
Results
Incidence and factors related to ventricular thrombus
before hospital discharge (Fig . 1) . A left ventricular throm-
bus was found on predischarge echocardiograms in 38 (31%)
of 124 patients with anterior and none of 74 patients with
inferior infarction (p < 0.001). Of the 38 thrombi, 18 (47%)
were mural and 20 (53%) were protruding . Six (16%) of the
JACC Vol. 15, No. 4
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Table 1 . Predischarge Clii cal and Echocaruiographic
f virrelations in 124 Patients With Anterior Wall Myocardial
Infarction (univariate analysis)
*Multiples of upper normai limit of creatie kinase (CK) level . tAtrial
fibrillation, ventricular tachycardia or fibrillation, complete heart block . Ant
= anterior ; CHF = congestive heart failure : CPR = cardiopulmonary resus-
tation ; echo = echocarliography : int' = inferior; LVEF = left ventricular
ejection fraction ; MI = myocardial infarction .
38 thrombi were mobile ; a,) 6 were of the protruding type .
Mean thrombus size was 3.2 ± 1 .6 cm 2 (range 0 .5 to 7.1) .
Comparison of clinical and laboratory data in patients
with anterior infarction with and i ;-ithout thro®nbaac (Table 1)
Table 2 . Results of Stepwise Logistic Itegre,s
.,ion Analysis
showed similar findings in the two groups, except that
patients with a thrombus were younger (p = 0 .02) and had a
higher prevalence of left ventricular ejection fraction <35%
(p = 0.01) . The incidence of hypokinetic apical contractility
was higher in patients without a thrombus (p = 0
.01),
whereas dyskinesia or left ventricular aneurysm, or both,
were more frequently found in patients with a thrombus (p =
0.006) .
Stepwise logistic regression analysis (Table 2) showed
that anterior location of the infarct, decreased left ventricu-
lar ejection fraction (35%) and apical dyskinesia or aneurysm
had the highest association with left ventricular thrombus
during hospitalization .
Effect of early throw holytic therapy . Streptokinase was
given to 34 patients (Fig . 1) ; 26 had anterior infarction and 11
(42%) of these had an apical thrombus . Six (55%) of the 11
thrombi were mural, 4 (36%®) were protruding and 1(9%®) was
mobile. The mean thrombus size was 2 .7 ± 1 .9 cm' . None of
these patients had evidenced thrombus on the first echocar-
diogram performed within 12 h of hospitalization . Among
these 26 patients, thrombus was found in 5 (63%) of 8
patients without and in 6 (33%) of 18 patients with reperfu-
sion (p = NS) . Among the 98 patients with anterior infarc .
Lion and no streptokinase therapy, 27 (28%) had a left
ventricular thrombus (p = NS compared with treated pa-
tients) . No significant differences were found among clinical
features, ejection fraction, type of thrombus or apical wall
motion between patients with and without streptokinase
therapy .
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*Because follow-up and predischarge left ventricular ejection fraction (LVEF) =_35% showed a high correlation
coefficient (r = 0
.79), the model arbitrarily included one of these variables
. because follow-up and predischarge
ventricular aneurysm showed a high correlation coefficient (r = 0
.81), the model arbitrarily also included one of these
variables
. #Apical aneurysm during follow-up showed a negative correlation coefficient (r = -0
.98) with apical
akinesia and could replace it in the model
. §Presence of presdischarge left ventricular thrombus showed a high
correlation coefficient (r = 0
.89) with thrombus mobility
. FU = follow-up; LV = left ventricular
; Pre = predischarge ;
other abbreviations as in Table 1 .
Variable Beta
Standard
Error Odds Ratio
p Valu.
Predischarge LV thrombus
Anterior MI (Pre)
2 .22 1 .08 9 .20
0.04
LVEF s35% (Pre)
1 .49 0 .52 4 .42
0 .005
Aneurysm (Pre)
1 .00 0.45
2 .73 0.03
Follow-up: new LV thrombus
Deterioration iii LV contractility (FU)
2 .46 0 .90 1) .80
0.006
LVEF <_35% (Pre)*
1 .54 0.69
4 .69 0 .02
Aneurysm (Pre)t
1.46 0.90
4 .31 0.05
Follow-up; disappearance of LV thrombus
No dyskinesialaneurysm (Pre)*
1 .59 0.80
4 .90 0 .03
Long-term anticoagulant therapy (FU)
1 .38 0 .92 ?
.00 0 .04
Systemic embolism
LV thrombus mobility (Pre)§
6 .80 0.43
6 .10 0.001
Left Ventricular
Thr,>mbus
Present
(n = 38)
Absent
(n = 86)
p Value
Age (yr) 59 13
64 ± 11
0 .02
Male 36(95%) 71 (83%) NS
Previous MI
30%)
22(26%)
NS
Ant + inf MI 4(11%) 1002%) NS
Maximal CK* 7.4 ± 3 .9 7.0 ± 4 .6 NS
CHF 14(37%) 43150%) NS
Arrhythmiast 10 (26%) 21 (24%) NS
Cardiogenic shock or CPR 4 (11°( t 14(16%x) NS
LVEF (%) 32 ± 11 40 ± 12 NS
LVEF =_?5% 34 189x) 57(66%) 0 .01
Apical wall motion (echo)
Hypokinesia 0 18 (21 1/c) 0 .01
Akincsia 2-1 (587() 52 46fff) NS
Dyskinesia/aueurys n 16(421/(, ) 16,19%) 0 .1N16
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Figure 2 . Posthospitalization appearance (LVT+) and disappear-
ance (LVT-) of left ventricular thrombus in 159 patients with at
least 6 months (mean 26 .6 ± 8.4) of echocardiographic follow-up .
*In two patients, thrombus recurred and resolved again during
further follow-up . Abbreviations as in Figure I .
Long-Term Echocardiographic
Follow-Up (Fig. 2)
An echocardiographic follow-up period of at least 6
months was accomplished in 159 patients . Predischarge
thrombus was foorid in 29 (31%) of the 95 patients with
anterior infarction and in none of the 64 patients with inferior
infarction .
Appearance of new left ventricular thrombus during fol-
low-up (Fig. 2). Of 130 patients without a predischarge
thrombus 13 (10%) had a new thrombus ; in 8 it was mural, in
5 it was protruding and in I of the latter it was mobile . The
mean size was 4.4 ± 4.3 cm 2 (range 1 .0 to 15 .0). The
thrombus was observed at a mean of 4 .6 ± 2.1 months after
hospital discharge, but in four cases it first appeared at >6
months of follow-up. When compared by univariate analysis
with the 117 patients without a new thrombus, the 13
patients with a new thrombus hed a significantly higher
prevalence of previous myocardial infarction (p = 0.005),
congestive heart failure during hospitalization and follow-up
(p < 0.05 for both), left ventricular aneurysm during hospi-
talization and follow-up (p = 0.001 for both), decreased left
ventricular ejection fraction during hospitalization and fol-
low-up (p < 0 .01 for both) and deterioration in left ventric-
ular contractility during follow-up (p = 0 .001). Deterioration
JACC Vol . 15, No. 4
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in apical contractility from hypokinesia to akinesia or from
akinesia to dyskinesia was similar in the two groups (p =
0.1) . Compared with the patients
with a predischarge throm-
bus, those with a new thrombus after discharge showed a
higher incidence of previous infarction (p = 0 .006) .
Logistic regression analysis revealed three variables to
be related to occurrence of a new left ventricular thrombus
after discharge (Table 2) : 1) deterioration in overall left
ventricular contractility during the follow-up period, 2) pre-
discharge left ventricular ejection fraction <_35%®, and
3) predischarge ventricular aneurysm or dyskinesia .
Disappearance and changes in morphology of predischarge
thrombus (Fig. 2). Three of the 38 patients with a predis-
charge thrombus were lost to follow-up study, 3 died and 3
underwent surgical procedures before repeat echocardio-
graphic studies . The remaining 29 patients were followed up
by echocardiography for ~6 months . Fourteen (48%) of the
29 predischarge thrombi disappeared during 6 .5 ± 3.7
months (range 2 to 13), and 10 of these 14 thrombi disap-
peared within 6 months . The thrombus persisted until the
end of the follow-up period in the other 15 patients (52%) .
and 13 (87%) of these showed no significant change in size .
The clinical features in the 14 patients with and the 15
without disappearance of thrombus were similar. However,
the predischarge echocardiogram disclosed apical akinesia in
11 (79%) of the 14 patients with disappearance but in only 6
(40%) of the 15 with persistence of thrombus (p = 0 .03) .
Apical aneurysm or dyskinesia was found in three patients
(21%) with thrombus disappearance and in nine (60%) of
those with thrombus persistence (p = 0 .03). Improvement or
deterioration in left ventricular global and apical contractility
was similar in patients with and without persistence of
thrombus .
The morphology of the 14 thrombi that disappeared (6
mural, 6 protruding and 2 mobile) and their size were similar
to those of the thrombi that persisted .
Changes in shape and mobility could be evaluated in 27
thrombi (2 thrombi could not be detected on the first
echocardiographic study after discharge) . In 6 (22%) of the
27 thrombi, a change occurred in thrombus shape ; 5 protrud-
ing thrombi became of the mural type and I mural thrombus
evolved into the protruding type. In four patients, the
thrombus lost its mobility during follow-up .
Stepwise logistic regression analysis (Table 2) disclosed
that two variables were related to disappearance of predis-
charge thrombi: 1) apical akinesia on the predischarge
echocardiogram, and 2) long-term anticoagulant therapy .
Long-term anticoagulant therapy . This was administered
to 19 of 130 patients without a predischarge thrombus ; a
thrombus did not occur in the 16 patients who continued
receiving anticoagulant therapy until the end of the follow-up
period (Fig. 3). Thrombus occurred in 13 (11%) of 114
patients without any or without continuous long-term anti-
coagulant therapy (p = NS) (Fig. 4). Three of these 13
JACC Vol . VS, No . 4
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Figure 4 . Formation of a left ventricular thrombus after hospital
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discharge . Upper panel : A, Patient with apical dyskinesia without
predischarge thrombus . B . Protruding thrombus (T) found 3 months
-Lifft-
later. C. Resolution of the thrombus after 5 months of warfarin
6/114(5%)
therapy . Lower panel : A, Patient with left ventricular (LV) aneu-
rysm (an) . Thrombus was not found before discharge and during 12
Figure 3
. Correlation between changes in echocardiographic incin months of echocardiographic follow-up study while warfarin was
dence of left ventricular thrombus and long-term anticoagulant
administered . B, A mobile thrombus (1) detected 3 months after
therapy during follow-up . Ac+ = long-term anticoagulants admin-
cessation of anticoagulant therapy, which resolved (C) within 2
istered ; Ac- = no anticoagulant therapy given, other abbreviations
months of renewed anticoagulant therapy. LA = left atrium ; RA
as in Figure 2 .
right atrium : RV = right v ;mtricie .
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patients had aneurysm and no thrombus while receiving
anticoagulant therapy for 3 to 21 months, but a thrombus did
occur 1 .5 to 3 months after cessation of anticoagulant
therapy . After diagnosis of a new thrombus, treatment with
warfarin was begun in all 13 patients, and the thrombus
resolved in I during a further follow-up period of 3 to 18
months (mean 6 .8 ± 4.9) (Fig . 3 and 4) .
Among the 29 patients with a predischarge thrombus,
long-term anticoagulant therapy was administered to 9 (Fig .
3). The thrombus disappeared in 7 (7890 of the 9 patients
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Table 3
. Use of Thrombolytic Agents for Lysis of Apical Mobile Thrombus During Acute
Myocardial Infarction in Four Patients
with and 7 (3517,)) of we 20 patients without anticoagulant
therapy (p < 0 .05). In five patients (three with aneurysm and
two with apical akinesia), warfarin therapy was stopped 3 to
12 months after resolution of the thrombus. However,
thrombus recurred in two patients with aneurysm and dis-
appeared again after renewal of anticoagulant therapy . In
none of the seven patients with thrombus resolution without
long-term anticoagulant therapy was recurrence of a throm-
bus seen .
Systemic embolism . Six (17%) of the 35 patients with a
thrombus on the predischarge evaluation had systemic em-
bolism during the follow-up period . None of the 154 patients
without a thrombus had systemic embolism (p < 0 .001) .
Among the 13 patients who developed a new thrombus
during the follow-up period and received long-term anti-
coagulant therapy thereafter, none had systemic embolism .
The time interval between hospital discharge and emboliza-
tion was 10 .9 ± 14.0 months (range I to 36), but four patients
had embolism within 6 months . Two, emboli were to a limb
and organized thrombus was retrieved at surgery . In four
patients, an ischemic type cerebrovascular accident was
diagnosed, and two of these patients died . Systemic embo-
lism occurred in I (7%) of 14 patients with a predischarge
mural thrombus, 1 (7%) of 15 with a protruding nonmobile
thrombus and 4 (66%) of the 6 with a protracting mobile
thrombus (p < 0 .001) .
Long-term anticoagulant therapy . Twenty-one patients
(9 with thrombus on the predischarge echocardiogram and 13
with a new thrombus during follow-up period) received
long-term anticoagulant therapy and none had systemic
embolism. Of the 26 patients with a thrombus without
anticoagulant treatment, 6 (23%) had an emboik' event (p <
0.02). Stepwise logistic regression analysis (Table ?) related
subsequent embolic events to presence of a protruding
mobile thrombus (p = 0.001).
Prognostic significance of a left ventricular thrombus .
Twenty-nine patients (15%) died among the 189 patients
observed during the 2 year follow-up period . Cause of death
was congestive heart failure in 12, recurrent myocardial
infarction in 5, sudden cardiac death in 8, cerebrovascular
accident in 2 and unknown in 2 . The mortality rate was 23%
Thrombolytic Therapy
*Fifteen percent of the original thrombus persisted and
embolized. M = male ; STK = streptokinase ; UK =
urokinase
: other abbreviations as in Table I .
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(8 of 35) in those with anterior infarction associated with a
predischarge thrombus, 15% (13 of 84) in those with anterior
infarction without a thrombus and I 1 % (8 of 70) in those with
inferior infarction (p = NS) . There were no significant
complications related to warfarin therapy .
Thrombolytic therapy for apical mobile thrombus (Table
3). Urokinase or streptokinase was used in four patients
who were not part of the consecutive series described here ;
Data on patients I and 2 have been previously published
(44,45) . All four patients had anterior infarction with apical
akinesia or dyskinesia, and the diagnosis of thrombus was
made on days 5 to 16 . Ejection fraction ranged from 28% to
46%. After diagnosis of thrombus, systemic heparinization
was applied for 48 to 72 h . During heparin therapy, Patient I
had a transient ischemic attack, with disappearance of the
smallest of three apical thrombi originally found. Because
heparin therapy did not change thrombus size or mobility,
urokinase or streptokinase was started . In all four cases, a
significant decrease in size of the thrombus, together with a
marked increase in its mobility was seen 8 to 12 h later . In
Patients I and 2, the thrombus disappeared without compli-
cations . In Patient 3, diplopia occurred 9 h after the start of
streptokinase infusion . Heparin infusion was continued, but
streptokinase administration was stopped for 24 h until
complete resolution of diplopia. The renewed streptokinase
infusion led to complication-free resolution of the thrombus .
Patient 4 had a large protruding mobile apical thrombus
that decreased significantly in size after 52 h of uncompli-
cated infusion of streptokinase . One hour later, the patient
suddenly lost consciousness and developed signs of a right
hemispheric stroke . Disappearance of the apical thrombus
was documented by immediate echocardiography ; computed
tomography excluded cerebral hemorrhage and showed the
presence of extensive right hemispheric infarction (Fig . 5) .
The p.Atient died a few days later .
Patients 1, 2 and 3 were discharged on long-term anti-
coagulant treatment . During 20 to 32 months of follow-up,
thrombus recurred in one patient after cessation of warfarin,
but disappeared again after renewal of anticoagulant ther-
apy .
Patient No .
Age (yr)/
Gender
Day Post
Ml Type
Duration
Ih)
Outcome
I
41/M 23 UK
36 Successful, no complications
2
451M 10
STK 14 Successful. no complications
3 591M
8 STK 64 Successful, transient diplopia
4 541M
8 STK 54 Stroke,* death
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Figure 5. Fatal cerebral embolism in a patient with a mobile apical
thrombus who received streptokinase . A, Echocardiogram showing
a large apical thrombus (T) (arrows) with a mobile protruding
portion . B, The thrombus after 52 h of uncomplicated sti optokinase
therapy . C, One hour later, signs of right hemispheric stroke
occurred and the thrombus disappeared . D, Computed tomography
showed extensive right hemispheric cerebral infarction (Cl) occu-
pying the territory of the right middle cerebral artery . L = left ;
my = mitral valve ; R = right ; tv = tricuspid valve .
Discussion
Determinants of ventricular thrombus appearance before
hospital discharge. Logistic regression analysis showed that
anterior location of the infarction, left ventricular ejection
fraction :s35% and apical dyskinesia or aneurysm were the
major variables related to thrombus formation . The 31%
incidence rate of left ventricular thrombus in anterior infarc-
tion and its absence in inferior infarction are in agreement
with previous reports (8-14) . In anterior infarction, furt.`er
clinical variables (such as previous infarction, congestive
heart failure, cardiogeaic shock, maximal serum enzyme
levels) did not separate patients with and without predis-
charge thrombus . Thus, on the basis of clinical criteria, all
patients with anterior infarction should be considered at high
risk of thrombus formatio .j . Decreased ejection fraction was
an independent predictor of (46) but not a prerequisite for
(11) thrombus formation . Thrombus is rare in the presence of
a preserved or only mildly decreased left ventricular ejection
fraction, but may occur in patients with an apical aneurysm,
as seen in four patients in this series
. Similar to find-ngs in
other studies (8,46),
apical dyskinesia or aneurysm corre-
lated better with thrombus occurrence by univariate (p =
UK (Table 1) or multivariate (p = (103) (Table 2) analysis
than did akinesia (p = NS) .
Effect of early fibrinolyfic therapy. This study did not
demonstrate a benefic;al effect of early fibrinolytic therapy
on left ventricular ejection fraction and the incidence of
thrombus. Sharma et al . (29) observed thrombus within 24 h
of streptokinase administration . In the present study, throm-
bus was found only after the lytic phase, while patients were
fully anticoagulated. The unusually high incidence of throm-
bus (42%) found in our patients with anterior infarction
receiving streptokinase may be related to the small number
of patients evaluated. However, two randomized (28,30) and
one uncontrolled (29) study showed an incidence of 26% to
55% of thrombus in similar patients . In contrast, Eigler et al .
(27) compared 12 patients treated with and 10 patients
without early thrombolytic therapy and found a significant
improvement in both ejection fraction and thrombus inci-
dence in the treated group . Our present study and a previous
study (30) showed a statistically nonsignificant trend toward
fewer thrombi in patients with successful reperfusion .
Appearance of ventricular thromLns during follow-up .
Prospective echocardiographic studies have shown that 33%
to 62% of thrombi detected during hospitalization are
present within 48 h of the acute event (18,20,24,27) and some
may be found at admission (20) . Few data (8, 18,20) are
available concerning the appearance of thrombi after hospi-
talization . In 13 (1017c) of our 130 patients. a thrombus first
developed during the follow-up period . This was found in
15% of patients with anterior and 5% of those with inferior
infarction . All patients with inferior infarction had either a
large inferior wall aneurysm or severe inferoapical asynergy .
The new thrombus occurred within 6 months of the infarc-
tion in 69% of cases, and in 38% of the cases, it was of the
protruding type (Fig . 4) . None of the 16 patients on contin-
uous anticoagulant therapy developed a thrombus during the
follow-up period compared with 11% of patients without
anticoagulant therapy (p = NS) .
Logistic regression analysis showed three factors to be
related to the occurrence of thrombus after hospital dis-
charge : 1) deterioration in left ventricular ejection fraction
during the f
P,:r;-J . '
.)
iniiiall,' low ejection fraction,
and 3) ventricular aneurysm or dyskinesia during hospital-
ization or follow-up . Previous infarction and congestive
heart failure showed a significant correlation with the occur-
rence of thrombus by univariate but not by stepwise logistic
regression analysis .
Disappearance of thrombus during follow-up. Logistic
regression analysis revealed that the type of apical wall
motion before and warfarin therapy after hospital discharge
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were the major factors associated with disappearance of
thrombus in 48% of the patients with a predischarge throm-
bus. Thrombus disappeared in 65% of patients with apical
akinesia but in only 25% of those with apical aneurysm or
dyskinesia (p = 0 .03). Seven of the 13 new thrombi found
after hospital discharge disappeared during further follow-up
(Fig. 4). Improvement in wall motion adjacent to the throm-
bus has been suggested as a possible mechanism for throm-
bus resolution (10) . The current study and others (20,22) do
not support this observation .
Thrombus disappeared in 78% of patients wcompared
w t only 35% of those without long-term anticoagulant
t erapy (p < 0 .05). A randomized study (32) of warfarin
therapy in patients with thrombus after acute myocardial
infarction demonstrated 88% versus 24°j~ disappearance
rates in treated and untreated patients, respectively . In
nonrandomized studies (8,10,11,18 .20,27,33) thrombus dis-
appearance rates have ranged from 42% to 84% with and
14% to 40% without long-term anticoagulant therapy . The
beneficial effect of long-term anticoagulant therapy has been
supported by indium-Ill platelet imaging, which showed
prolonged (months to years) surface activity of thrombi with
active platelet deposition (47,48) and inhibition of this activ-
ity by warfarin in some cases (48) . Furthermore, there are
reports (8,20) of thrombus reappearance after cessation of
anticoagulation therapy . to this study and another study
(20), thrombus recurred after cessation of anticoagulants
only in patients with aneursym or dyskinesia, not in those
with apical akinesia.
Systemic embolism . Previous studies (8-21,25,26,33)
have demonstrated systemic embolism in 147 (20%) of 746
patients (range 4% to 63%) with echocardiographically doc-
umented ventricular thrombus, but in only 16 of 785 patients
(2%, range 0 to 4%) without thrombus . In this study,
systemic embolism occurred in 6 (17%) of 35 patients with a
thrombus, but in none of the 154 patients without a predis-
charge thrombus (p < 0.001) . Clinical and nuclear angio-
graphic variables were not predictive of embolic events .
Although most embolic events occur within 6 months of
infarction, ventricular thrombus continued to represent an
increased risk for systemic embolism in the current and
previous (12-15) reports .
Thrombus mobility on predischarge echocardiographv
showed the best
correlation with subsequent embolic events
(p < 0 .001), The incidence of embolism in patients with a
mobile thrombus has ranged from 13% to 83% (11-17) and, in
most cases, mobile thrombi were of the protruding type
(13-20). The reported average rates of systemic embolism
were 55% (47 of 86) in protruding mobile, 18% (18 of 102) in
protruding nonmobile and 10% (25 of 255) in mural thrombi
(11-16,18)
. Changes in thrombus shape and mobility were
common when evaluated from the first day of infarction (18),
but were rare in patients evaluated ?3 months after the acute
event (33) . In the present study,
the morphologic character-
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istics of persistent thrombus defined before hospital dis-
charge remained relatively stable and were predictive of
subsequent embolic events. A thrombus formed after hospi-
tal discharge was not associated with systemic embolism .
However, in this group, there was only one patient with a
mobile thrombus, and long-term anticoagulant therapy was
given to all patients immediately after detection of thrombus .
Further studies are needed to evaluate the embolic potential
of thrombi formed during follow-up .
It has been suggested that long-term anticoagulant ther-
apy is not indicated in patients with ventricular aneurysm
because of a low incidence of embolism (6,49-51) . In the
current series, three of six emboli occurred in patients with
a ventricular aneurysm . Moreover, cessation of anticoagu-
lant therapy after periods of up to 2 years was associated
with either recurrence or first appearance of a new thrombus
only in patients with aneurysm . Similar to our results, other
investigators (12,15,17) found the same incidence of embo-
lism in patients with and without aneurysm, and Reeder et
al. (52) demonstrated that in patients with aneurysm, the
frequency of systemic embolism decreased significantly with
longer periods of anticoagulant therapy.
Fibrinolytic therapy in patients with a mobile apical throm-
bus. Kremer et al . (43) reported lysis of a protruding throm-
bus in 10 of 16 patients after acute myocardial infarction . At
least three of their patients had a mobile thrombus . The
treatment was successful in eight of nine patients within 4
weeks of the acute infarction . None of the patients had
clinical embolism, and only in one was therapy discontinued
because of hematuria . Shenoy et al . (53) reported successful
lysis of an apical mural thrombus with streptokinase . Con-
sidering the foregoing discussion, we selectively applied this
therapy to four patients with a protruding mobile thrombus .
In the first two previously reported cases (44,45), lysis of
thrombus was achieved without complication . In the latter
two cases, however, systemic embolism occurred, with
transient diplopia in one and stroke followed by death in the
other. This experience confirms that fibrinolytic agents are
capable of lysing ventricular thrombi but suggests that the
risks of this therapy may be higher than previously assumed .
Limitations of the study. This was an observational study
in which anticoagulant and fibrinolytic therapies were not
controlled and were applied to a small number of patients .
Therefore, the results regarding these therapies are not
conclusive. The data regarding resolution and appearance of
a new thrombus during the follow-up period can be applied
only to long-term survivors on medical therapy because
echocardiographic follow-up of ?6 months was not available
in approximately 20% of the patients, mostly because of
death or operative interventions during that time period . The
results of univar9 .ate statistical .analysis should be considered
with caution given the multiple comparisons made . How-
ever, we also used logistic regression analysis, which elim-
inated fortuitous statistical significance .
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Clinical implications. The results of this study support
the view that echocardiography should be routinely per-
formed before hospital discharge in all patients with acute
anterior myocardial infarction (54,55) to 1) diagnose patients
with ventricuiar thrombus and those with a protruding
mobile thrombus who are at especially high risk of embo-
lization ; 2) define patients at risk of developing thrombus
after hospital discharge ; and 3) identify patients who may
undergo resolution of thrombus during follow-up . We did not
demonstrate a reduction in incidence of lentricular throm-
bus by early fib inoytiQ therapy and a full dose of anticoag-
ulants during the acute phase of infarct'an . However, long-
term anticoagulant therapy applied to a relatively small
number of patients in the posthospitalization period was
associated with an increased resolution rate of thrombus and
with prevention of systemic embolism in patients with doc-
umented thrombus . Long-term anticoagulant therapy under
echocardiographic guidance is probably indicated until res-
olution of the thrombus is seen on the follow-up echocardio-
gram. 1A eighing the risk-benefit ratio, long-term anticoagu-
lant therapy may be given indefinitely to selected patients
with left ventricular aneurysm, decreased or deteriorating
left ventricular ejection fraction (that is, in the presence of
the factors that predispose to occurrence of a new thrombus
during the follow-up period) . Lysis of fresh thrombi with
thrombolytic agents is feasible, but may be associated with
death. More data are needed before thrombolysis is acceptea
as the therapy of choice in patients with a mobile thrombus
(56) .
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